Status:
COMPLETED
Effect of Quercetin Supplements on Healthy Males: a Four-Week Randomized Cross-Over Trial
Lead Sponsor:
University of Leeds
Conditions:
Hyperuricemia
Gout
Eligibility:
MALE
19-65 years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this study was to test the effect of chronic consumption of Quercetin 500 mg tablets on blood uric acid and other biomarkers in adult males.
Detailed Description
The main goal of the research is to determine the long term effects of daily supplementation of quercetin, a compound naturally and normally present in food, on the chemical composition (uric acid ii ...
Eligibility Criteria
Inclusion
- Written informed consent
- Plasma Uric Acid \> 300 micro Mole/L
- Generally Healthy
Exclusion
- Body Mass Index (BMI) ≥ 30 kg/m² or \<18.5 kg/m²
- Unable or unwilling to comply with the protocol, or likely to leave the study before its completion.
- Who would undertake important change in physical exercise or vigorous sport competitions during the study period.
- regularly drink more than 3 units of alcohol every day
- smokers
- have history of treated hyperuricemia, gout and/ or kidney stone
- have intestinal disorders
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01881919
Start Date
February 1 2013
End Date
November 1 2014
Last Update
March 24 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Food Science and Nutrition
Leeds, West Yorkshire, United Kingdom, LS2 9JT